Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

GPC Biotech launches satraplatin expanded access program

Feb. 23, 2007

Identification of active sites of Polo-like kinases useful for developing new cancer therapies

Feb. 23, 2007

Recent patents cover new therapeutic agents for cancer

Feb. 23, 2007

Vascular disruption agent BNC-105 begins safety studies in animals

Feb. 22, 2007

Disruption of the CXCR4-CXCL12 and VLA4-VCAM-1 axes may sensitize leukemia cells to chemotherapy

Feb. 22, 2007

Avalon begins drug discovery program targeting MYC oncoprotein

Feb. 22, 2007

Noscapine shows efficacy in prostate cancer

Feb. 22, 2007

Novel anticancer compounds described in recent patents

Feb. 22, 2007

ZIO-101 well tolerated in phase I study in multiple myeloma

Feb. 21, 2007

SGX reviews oncology pipeline

Feb. 20, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...